Title:
EPHA2 CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/016129
Kind Code:
A1
Abstract:
Provided in the present invention are a new chimeric antigen receptor that specifically binds to EPHA2, and the use thereof.
More Like This:
Inventors:
ZHONG XIAOSONG (CN)
AN ZHIJING (CN)
BAI YUE (CN)
HU YI (CN)
AN ZHIJING (CN)
BAI YUE (CN)
HU YI (CN)
Application Number:
PCT/CN2022/102889
Publication Date:
February 16, 2023
Filing Date:
June 30, 2022
Export Citation:
Assignee:
CARRIAGE PHARMACEUTIC BEIJING CO LTD (CN)
International Classes:
C07K19/00; A61K39/00; A61K45/06; A61P35/00; C12N5/10; C12N15/62; C12N15/867; G01N33/68
Foreign References:
CN113980138A | 2022-01-28 | |||
CN110078830A | 2019-08-02 | |||
CN108778328A | 2018-11-09 | |||
CN106047817A | 2016-10-26 |
Other References:
YI ZHONGZHEN, PRINZING BROOKE L., CAO FELICIA, GOTTSCHALK STEPHEN, KRENCIUTE GIEDRE: "Optimizing EphA2-CAR T Cells for the Adoptive Immunotherapy of Glioma", MOLECULAR THERAPY- METHODS & CLINICAL DEVELOPMENT, NATURE PUBLISHING GROUP, GB, vol. 9, 15 June 2018 (2018-06-15), GB , pages 70 - 80, XP093032868, ISSN: 2329-0501, DOI: 10.1016/j.omtm.2018.01.009
Attorney, Agent or Firm:
ZHONGZI LAW OFFICE (CN)
Download PDF: